TrialHaematologica2019

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial.

Rohtesh S Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.